Search Within

Weinberg Fellows

  1. "Gynecology Disease Management Team "
Formats
  1. Journal Article (188)
  2. Meeting Abstract (181)
  3. Review (20)
  4. Editorial (11)
  5. Book Section (4)
  6. Correspondence (3)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (409)
  2. Hematology-Oncology Fellows (400)
  3. Department of Medicine (392)
  4. Solid Tumor Oncology Division (388)
  5. GDMT, Medicine (346)
  6. Gynecologic Medicine Service (299)

More Groups

People
  1. Claire Friedman (123)
  2. Carol Aghajanian (82)
  3. Britta Weigelt (81)
  4. Vicky Makker (62)
  5. Dmitriy Zamarin (58)
  6. Michael Berger (49)

More People

Years
  1. 2025 (39)
  2. 2024 (58)
  3. 2023 (49)
  4. 2022 (77)
  5. 2021 (51)
  6. 2020 (49)

More Years

Publications
  1. Journal of Clinical Oncology (91)
  2. Gynecologic Oncology (41)
  3. Annals of Oncology (28)
  4. Clinical Cancer Research (17)
  5. Cancer Research (16)
  6. International Journal of Gynecological Cancer (16)

More Publications

Publishers
  1. American Society of Clinical Oncology (106)
  2. Elsevier B.V. (47)
  3. American Association for Cancer Research (46)
  4. Oxford University Press (36)
  5. Nature Publishing Group (33)
  6. Elsevier Inc. (22)

More Publishers

Results (409)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health disparities among women who received treatment for 1L advanced and recurrent endometrial cancer in the United States
    Meeting Abstract

    McClain, K. M.; Prabhu, V. S.; Marupuru, S.; Meng, K.; Tran, V.; Woodhouse, K.; Meng, R.; Green, A. K.; Makker, V.
    Cancer Epidemiology Biomarkers and Prevention (2025)

    Fulltext@MSK | Save
  • Sensitive HLA-independent T cell receptors overcome tumor antigen heterogeneity in solid tumors
    Meeting Abstract

    Hanina, S.; Park, T.; Lopez, M.; Rajasekhar, V.; Mansilla-Soto, J.; Haubner, S.; Zhao, H.; Banerjee, P.; Koche, R.; Hamard, P. J.; more...
    Molecular Therapy (2025)

    Fulltext@MSK | Save
  • A first-in-human phase 1 study Of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors (trial in progress)
    Meeting Abstract

    Ray-Coquard, I. L.; O'Malley, D. M.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R. N.; Westin, S. N.; Lakhani, N.; McKean, W. B.; Koyama, T.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Phase I/II clinical investigation of invikafusp alfa, a first-in-class TCR-beta chain-targeted bispecific antibody, as monotherapy in patients with anti-PD(L)1-resistant, antigen-rich gastrointestinal (GI) cancers
    Meeting Abstract

    Fernandez, E. E.; Garralda, E.; Parikh, A.; Italiano, A.; Hollebecque, A.; Marabelle, A.; Friedman, C.; Sullivan, R.; Tschernia, N.; Juarez, M. M. H.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
    Journal Article

    Sia, T. Y.; Moufarrij, S.; Milani, J.; Kane, S.; Zhou, Q.; Fong, C.; Khurram, A.; Kemel, Y. M.; Sheehan, M.; Latham, A.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
    Journal Article

    Liu, J. F.; Colombo, N.; Oza, A. M.; Frenel, J. S.; Corr, B. R.; Rubinstein, M. M.; Nevadunsky, N. S.; Lheureux, S.; Gaba, L.; González Cortijo, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Neoplasia detection via colonic surveillance among young individuals with MSH6 and PMS2 -associated Lynch Syndrome
    Journal Article

    Latham, A.; Liu, Y. L.; Constantino, G.; Borio, M.; McCoy, S.; Dudzik, C.; Heiman, J.; Kemel, Y.; Ukaegbu, C.; Carlo, M. I.; more...
    American Journal of Gastroenterology (2025)

    Fulltext@MSK | Save
  • Therapeutic targeting of mismatch repair-deficient cancers
    Review

    Johannet, P.; Rousseau, B.; Aghajanian, C.; Foote, M. B.; Diaz, L. A. Jr
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save